Great Point Partners as of Dec. 31, 2021
Portfolio Holdings for Great Point Partners
Great Point Partners holds 36 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arena Pharmaceuticals Com New | 11.0 | $49M | 531k | 92.94 | |
| Exelixis (EXEL) | 7.1 | $32M | 1.8M | 18.28 | |
| Xenon Pharmaceuticals (XENE) | 6.6 | $30M | 950k | 31.24 | |
| Travere Therapeutics (TVTX) | 5.5 | $25M | 800k | 31.04 | |
| Anaptysbio Inc Common (ANAB) | 4.6 | $21M | 592k | 34.75 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.1 | $19M | 85k | 219.60 | |
| Bioatla (BCAB) | 3.8 | $17M | 864k | 19.63 | |
| Galapagos Nv Spon Adr (GLPG) | 3.7 | $17M | 300k | 55.13 | |
| Relmada Therapeutics (RLMD) | 3.6 | $16M | 717k | 22.53 | |
| Macrogenics (MGNX) | 3.6 | $16M | 1.0M | 16.05 | |
| Cytokinetics Com New (CYTK) | 3.5 | $16M | 350k | 45.58 | |
| Tricida | 3.0 | $13M | 1.4M | 9.56 | |
| Rigel Pharmaceuticals Com New (RIGL) | 2.9 | $13M | 5.0M | 2.65 | |
| Sarepta Therapeutics (SRPT) | 2.9 | $13M | 145k | 90.05 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 2.7 | $12M | 200k | 60.87 | |
| Vaxcyte (PCVX) | 2.6 | $12M | 500k | 23.79 | |
| Avidity Biosciences Ord (RNA) | 2.6 | $12M | 500k | 23.77 | |
| Aclaris Therapeutics (ACRS) | 2.6 | $12M | 800k | 14.54 | |
| Rocket Pharmaceuticals (RCKT) | 2.4 | $11M | 501k | 21.83 | |
| Silence Therapeutics Ads (SLN) | 2.4 | $11M | 444k | 23.89 | |
| Dyne Therapeutics (DYN) | 2.2 | $10M | 845k | 11.89 | |
| Passage Bio (PASG) | 2.1 | $9.6M | 1.5M | 6.35 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 2.0 | $9.0M | 1.1M | 8.01 | |
| Urogen Pharma (URGN) | 1.8 | $8.3M | 873k | 9.51 | |
| Chinook Therapeutics | 1.4 | $6.4M | 390k | 16.31 | |
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 1.4 | $6.3M | 537k | 11.77 | |
| Pieris Pharmaceuticals (PIRS) | 1.3 | $5.9M | 1.6M | 3.78 | |
| Kalvista Pharmaceuticals (KALV) | 1.2 | $5.5M | 412k | 13.23 | |
| Magenta Therapeutics | 1.2 | $5.2M | 1.2M | 4.43 | |
| Pyxis Oncology Common Stock (PYXS) | 1.0 | $4.4M | 400k | 10.97 | |
| Aeglea Biotherapeutics | 1.0 | $4.3M | 910k | 4.75 | |
| Nektar Therapeutics Call Option (NKTR) | 0.6 | $2.8M | 204k | 13.51 | |
| Arbutus Biopharma (ABUS) | 0.6 | $2.6M | 669k | 3.89 | |
| Cabaletta Bio (CABA) | 0.4 | $1.8M | 472k | 3.79 | |
| Rafael Hldgs Com Cl B (RFL) | 0.3 | $1.5M | 286k | 5.10 | |
| Point Biopharma Global | 0.2 | $1.1M | 191k | 5.60 |
